VATE Fundamental Analysis - INNOVATE CORP

Fundamental Rating

Overall VATE gets a fundamental rating of 2 out of 10. We evaluated VATE against 54 industry peers in the Construction & Engineering industry. Both the profitability and financial health of VATE have multiple concerns. VATE is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

VATE had negative earnings in the past year.

In the past year VATE had a positive cash flow from operations.

VATE had negative earnings in each of the past 5 years.

VATE had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -8.83%, VATE is doing worse than 79.63% of the companies in the same industry.

With an excellent Return On Invested Capital value of 91.87%, VATE belongs to the best of the industry, outperforming 98.15% of the companies in the same industry.

VATE had an Average Return On Invested Capital over the past 3 years of 4.95%. This is significantly below the industry average of 18.23%.

The 3 year average ROIC (4.95%) for VATE is below the current ROIC(91.87%), indicating increased profibility in the last year.

		Industry Rank	Sector Rank
ROA	-8.83%
ROE	N/A
ROIC	91.87%

ROA(3y)-3.72%

ROA(5y)-6.77%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)4.95%

ROIC(5y)N/A

1.3 Margins

VATE's Operating Margin of 2.08% is on the low side compared to the rest of the industry. VATE is outperformed by 66.67% of its industry peers.

In the last couple of years the Operating Margin of VATE has declined.

VATE has a Gross Margin (18.66%) which is comparable to the rest of the industry.

In the last couple of years the Gross Margin of VATE has declined.

		Industry Rank	Sector Rank
OM	2.08%
PM (TTM)	N/A
GM	18.66%

OM growth 3YN/A

OM growth 5Y-8.91%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y7.36%

GM growth 5Y-15.84%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so VATE is creating value.

VATE has more shares outstanding than it did 1 year ago.

The number of shares outstanding for VATE has been reduced compared to 5 years ago.

The debt/assets ratio for VATE is higher compared to a year ago.

2.2 Solvency

VATE has an Altman-Z score of -0.30. This is a bad value and indicates that VATE is not financially healthy and even has some risk of bankruptcy.

Looking at the Altman-Z score, with a value of -0.30, VATE is doing worse than 88.89% of the companies in the same industry.

The Debt to FCF ratio of VATE is 35.03, which is on the high side as it means it would take VATE, 35.03 years of fcf income to pay off all of its debts.

Looking at the Debt to FCF ratio, with a value of 35.03, VATE is in line with its industry, outperforming 44.44% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	35.03
Altman-Z	-0.3

ROIC/WACC14.07

WACC6.53%

2.3 Liquidity

A Current Ratio of 0.46 indicates that VATE may have some problems paying its short term obligations.

VATE has a Current ratio of 0.46. This is amonst the worse of the industry: VATE underperforms 87.04% of its industry peers.

A Quick Ratio of 0.43 indicates that VATE may have some problems paying its short term obligations.

Looking at the Quick ratio, with a value of 0.43, VATE is doing worse than 87.04% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	0.46
Quick Ratio	0.43

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

VATE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1015.04%.

VATE shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -27.08%.

Measured over the past years, VATE shows a small growth in Revenue. The Revenue has been growing by 0.55% on average per year.

EPS 1Y (TTM)-1015.04%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-1770%

Revenue 1Y (TTM)-27.08%

Revenue growth 3Y-2.79%

Revenue growth 5Y0.55%

Sales Q2Q%-22.71%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

VATE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

VATE's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. VATE is cheaper than 81.48% of the companies in the same industry.

VATE's Price/Free Cash Flow ratio is rather cheap when compared to the industry. VATE is cheaper than 100.00% of the companies in the same industry.

		Industry Rank	Sector Rank
P/FCF	3.82
EV/EBITDA	12.98

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

VATE does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

INNOVATE CORP

NYSE:VATE (12/24/2025, 8:05:20 PM)

5.09

+0.07 (+1.39%)

Chartmill FA Rating

GICS SectorIndustrials

GICS IndustryGroupCapital Goods

GICS IndustryConstruction & Engineering

Earnings (Last)11-12 2025-11-12

Earnings (Next)03-30 2026-03-30

Inst Owners18.6%

Inst Owner Change-3.44%

Ins Owners51.75%

Ins Owner Change8.94%

Market Cap69.53M

Revenue(TTM)995.00M

Net Income(TTM)-78.70M

Analysts82.86

Price TargetN/A

Short Float %5.45%

Short Ratio9.67

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly Dividend0.11

Dividend Growth(5Y)0.76%

DP-2.16%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.07
P/FCF	3.82
P/OCF	1.77
P/B	N/A
P/tB	N/A
EV/EBITDA	12.98

EPS(TTM)-6.01

EYN/A

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)1.33

FCFY26.18%

OCF(TTM)2.88

OCFY56.52%

SpS72.84

BVpS-15.2

TBVpS-36.84

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-8.83%
ROE	N/A
ROCE	116.29%
ROIC	91.87%
ROICexc	N/A
ROICexgc	N/A
OM	2.08%
PM (TTM)	N/A
GM	18.66%
FCFM	1.83%

ROA(3y)-3.72%

ROA(5y)-6.77%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)4.95%

ROIC(5y)N/A

ROICexc(3y)5.63%

ROICexc(5y)N/A

ROICexgc(3y)24.72%

ROICexgc(5y)N/A

ROCE(3y)6.27%

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5Y-8.91%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y7.36%

GM growth 5Y-15.84%

F-Score4

Asset Turnover1.12

Health

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	35.03
Debt/EBITDA	3.08
Cap/Depr	67.63%
Cap/Sales	2.12%
Interest Coverage	0.42
Cash Conversion	75.72%
Profit Quality	N/A
Current Ratio	0.46
Quick Ratio	0.43
Altman-Z	-0.3

F-Score4

WACC6.53%

ROIC/WACC14.07

Cap/Depr(3y)52.64%

Cap/Depr(5y)57.69%

Cap/Sales(3y)1.42%

Cap/Sales(5y)1.75%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-1015.04%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-1770%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-27.08%

Revenue growth 3Y-2.79%

Revenue growth 5Y0.55%

Sales Q2Q%-22.71%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-65.15%

EBIT growth 3YN/A

EBIT growth 5Y-8.4%

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y138.16%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y242.39%

OCF growth 3Y-65.54%

OCF growth 5Y-39.31%

INNOVATE CORP / VATE FAQ

What is the fundamental rating for VATE stock?

ChartMill assigns a fundamental rating of 2 / 10 to VATE.

What is the valuation status of INNOVATE CORP (VATE) stock?

ChartMill assigns a valuation rating of 2 / 10 to INNOVATE CORP (VATE). This can be considered as Overvalued.

What is the profitability of VATE stock?

INNOVATE CORP (VATE) has a profitability rating of 2 / 10.

Can you provide the dividend sustainability for VATE stock?

The dividend rating of INNOVATE CORP (VATE) is 0 / 10 and the dividend payout ratio is -2.16%.

INNOVATE CORP (VATE) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

INNOVATE CORP / VATE FAQ

What is the fundamental rating for VATE stock?

What is the valuation status of INNOVATE CORP (VATE) stock?

What is the profitability of VATE stock?

Can you provide the dividend sustainability for VATE stock?